Allergan (AGN +0.5%) and Molecular Partners have entered into two separate agreements to...

|About: Allergan plc (AGN)|By:, SA News Editor

Allergan (AGN +0.5%) and Molecular Partners have entered into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases, with a specific emphasis on age-related macular degeneration.